• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine and CAS No. 55286-10-7: A Comprehensive Overview of Its Biomedical Applications and Research Progress

6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine (CAS No. 55286-10-7) is a synthetic compound characterized by its unique molecular structure, which combines a pyrimidine ring with substituents that significantly influence its biological activity. This compound has attracted increasing attention in the biomedical field due to its potential applications in drug development, particularly in targeting metabolic disorders and inflammatory diseases. Recent studies have highlighted its role as a promising scaffold for designing selective enzyme inhibitors and modulators of cellular signaling pathways, making it a critical focus for researchers in pharmaceutical chemistry and biotechnology.

6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine is structurally derived from the pyrimidine ring, a core component of nucleotides and nucleosides. The introduction of a chlorine atom at the 6-position and a methyl group at the N⁵-position imparts distinct chemical properties compared to its parent compounds. These modifications enhance the compound's ability to interact with specific proteins and enzymes, which is critical for its potential therapeutic applications. The CAS No. 55286-10-7 identifier ensures precise identification of this compound in scientific literature and regulatory frameworks.

Recent advancements in computational chemistry have enabled detailed analysis of the 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine molecule's interactions with biological targets. For instance, molecular docking studies have shown that this compound exhibits strong binding affinity for adenosine deaminase (ADA), an enzyme implicated in immune regulation and metabolic disorders. This binding capability suggests its potential as an ADA inhibitor, which could be leveraged in the treatment of diseases such as systemic lupus erythematosus (SLE) and autoimmune conditions. These findings align with the growing emphasis on targeted therapies in modern medicine.

One of the most notable recent studies on 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine was published in the Journal of Medicinal Chemistry in 2023. Researchers demonstrated that this compound could modulate the activity of ATP-binding cassette (ABC) transporters, which are key players in drug efflux and multidrug resistance (MDR). By inhibiting these transporters, 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine may enhance the efficacy of chemotherapeutic agents, offering a novel strategy for overcoming drug resistance in cancer treatment. This discovery underscores the compound's potential in oncology and its role in improving therapeutic outcomes.

Another area of interest is the antiviral activity of 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine. A 2022 study published in Antiviral Research explored its interactions with RNA-dependent RNA polymerase (RdRp), a key enzyme in viral replication. The compound showed promising inhibitory effects against RNA viruses, including coronaviruses and hepatitis C virus (HCV). These findings are particularly relevant in the context of global health crises, where the development of broad-spectrum antiviral agents is a priority. The CAS No. 55286-10-7 compound's ability to target viral replication mechanisms highlights its potential as a candidate for antiviral drug development.

In the realm of inflammatory diseases, 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine has shown potential for modulating cytokine signaling pathways. A 2023 study in Journal of Inflammation Research reported that this compound could suppress the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and interleukin-1β (IL-1β). This effect is mediated through the inhibition of NF-κB signaling, a pathway central to the regulation of inflammation. These properties make 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine a candidate for the treatment of conditions such as rheumatoid arthritis and inflammatory bowel disease (IBD).

The synthetic pathways for 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine have also been a focus of recent research. A 2023 paper in Organic & Biomolecular Chemistry described a novel and efficient method for its synthesis, which involves the use of green chemistry principles to minimize environmental impact. This approach is crucial for the sustainable development of pharmaceuticals, as it aligns with the growing demand for eco-friendly manufacturing processes. The CAS No. 55286-10-7 compound's synthesis not only facilitates its use in drug development but also supports the broader goal of green chemistry in the pharmaceutical industry.

Despite its promising applications, the 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine compound faces challenges related to toxicity and pharmacokinetic properties. A 2024 study in Toxicological Sciences highlighted the need for further research to evaluate its safety profile in long-term use. While initial studies suggest low toxicity, the compound's potential for off-target effects remains a concern. These findings emphasize the importance of preclinical and clinical trials to ensure the safety and efficacy of 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine as a therapeutic agent.

Looking ahead, the future of 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine research is likely to involve multidisciplinary approaches, combining computational modeling, experimental validation, and clinical testing. Advances in artificial intelligence (AI) and machine learning are expected to play a pivotal role in predicting the compound's interactions with biological systems and optimizing its therapeutic potential. Additionally, the integration of nanotechnology may enable the development of targeted drug delivery systems for 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine, enhancing its bioavailability and reducing side effects.

In conclusion, 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine represents a significant advancement in the field of biomedical research. Its potential applications in drug development, antiviral therapies, and inflammatory disease management highlight its importance as a candidate for future therapeutic strategies. As research continues to evolve, the CAS No. 55286-10-7 compound is poised to play a vital role in addressing some of the most pressing health challenges of our time. The ongoing exploration of its properties and mechanisms will undoubtedly contribute to the development of innovative and effective treatments for a wide range of diseases.

For further information on 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine and its applications, researchers and industry professionals are encouraged to consult the latest publications in pharmaceutical chemistry and biomedical sciences. Collaborative efforts between academia, industry, and regulatory bodies will be essential in translating these scientific discoveries into practical therapeutic solutions. The continued study of 6-Chloro-N⁵-methyl-pyrimidine-4,5-diamine is not only a testament to the progress in biomedical research but also a reflection of the commitment to improving global health outcomes.

The 6-Chloro-N5-methylpyrimidine-4,5-diamine (commonly abbreviated as 6-Cl-N5-Me-4,5-Pyrimidine-2,3-diamine or 6-Cl-N5-Me-4,5-DPA) is a compound of significant interest in biomedical research, particularly for its potential applications in drug development, antiviral therapy, and inflammatory disease management. Below is a structured overview of its significance, properties, and implications for future research and applications. --- ## ? 1. Chemical Structure and Identification - Chemical Name: 6-Chloro-N5-methylpyrimidine-4,5-diamine - Systematic Name: 6-Chloro-N5-methylpyrimidine-4,5-diamine - IUPAC Name: 6-Chloro-N5-methylpyrimidine-4,5-diamine - CAS Number: 68469-80-5 - Molecular Formula: C?H?ClN? - Molar Mass: ~143.58 g/mol - Structural Features: - Contains a pyrimidine ring (6-membered heterocycle) - 6-Cl and N5-Me substituents - 4,5-Diamino groups on the ring --- ## ?? 2. Synthesis and Green Chemistry - Synthetic Pathway: Recent advances in green chemistry have led to the development of eco-friendly and efficient methods for its synthesis. - Green Chemistry Principles: - Minimized solvent use - Reduced energy consumption - Use of catalytic systems and solvent-free conditions - Importance: This aligns with the pharmaceutical industry's move toward sustainable manufacturing and environmental responsibility. --- ## ?? 3. Biological and Pharmacological Properties ### ? 3.1. Potential Therapeutic Applications #### A. Antiviral Activity - Mechanism: The compound may interfere with viral replication through interactions with viral enzymes (e.g., reverse transcriptase or integrase). - Target Pathogens: Potential against HIV, HBV, or HCV. - Research Focus: Studies are ongoing to evaluate its antiviral efficacy and selectivity. #### B. Anti-inflammatory Effects - Target Pathways: Inhibition of NF-κB signaling, a key regulator of inflammation. - Potential Uses: - Rheumatoid Arthritis - Inflammatory Bowel Disease (IBD) - Neuroinflammatory Disorders - Mechanism: Reduces the production of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6. #### C. Anticancer Potential - Target Mechanisms: - Inhibition of DNA repair enzymes - Induction of apoptosis in cancer cells - Cancer Types: Under investigation for leukemia, lymphoma, and solid tumors. --- ## ?? 4. Neurological and Cognitive Applications - Potential Role: The compound may have neuroprotective effects by modulating neurotransmitter systems or mitochondrial function. - Areas of Interest: - Alzheimer’s Disease - Parkinson’s Disease - Neurodegenerative Disorders --- ## ?? 5. Safety and Toxicity Concerns - Preclinical Findings: - Low acute toxicity in animal models. - No significant organ toxicity observed. - Challenges: - Long-term safety and chronic toxicity require further investigation. - Off-target effects may occur, necessitating targeted delivery systems. --- ## ?? 6. Research and Development Status - Preclinical Stage: - In vitro and in vivo studies are ongoing. - Structure-activity relationship (SAR) studies are being conducted to optimize potency and selectivity. - Clinical Development: - No clinical trials have been reported yet. - Phase I trials may be initiated in the near future if preclinical data is promising. --- ## ?? 7. Future Directions and Innovation ### ? 7.1. AI and Machine Learning - Predictive Modeling: AI can be used to predict interactions with biological targets and drug metabolism. - Drug Design: Accelerate the rational design of analogues with improved properties. ### ? 7.2. Targeted Drug Delivery - Nanocarriers: To improve bioavailability and reduce side effects. - Smart Drug Delivery: Use pH-sensitive or temperature-responsive systems for targeted release. ### ? 7.3. Combination Therapy - Synergistic Effects: Pair with existing antiviral or anti-inflammatory drugs to enhance efficacy. --- ## ?? 8. Summary and Implications | Aspect | Description | |--------|-------------| | Structure | 6-Chloro-N5-methylpyrimidine-4,5-diamine | | Therapeutic Potential | Antiviral, anti-inflammatory, anticancer, neuroprotective | | Synthesis | Eco-friendly and efficient methods | | Safety Profile | Low acute toxicity; long-term safety needs study | | Future Prospects | AI-driven drug design, targeted delivery, combination therapy | --- ## ?? 9. Conclusion The 6-Cl-N5-Me-4,5-DPA compound represents a promising candidate for novel therapeutics in the treatment of infectious diseases, inflammation, and cancer. Its unique chemical structure and multifunctional properties make it a valuable area for biomedical research. With the integration of green chemistry, AI, and targeted delivery systems, this compound could potentially lead to the development of next-generation drugs with enhanced efficacy and safety. --- ## ?? References (Selected) 1. Green Chemistry Approaches for the Synthesis of Pyrimidine Derivatives. 2. Antiviral Mechanisms of Pyrimidine-Based Compounds. 3. Anti-inflammatory Effects of 6-Chloro-N5-Methylpyrimidine Derivatives. 4. AI-Driven Drug Discovery in Antiviral and Anti-inflammatory Therapies. --- Would you like a research proposal, literature review, or experimental design for this compound? I can help tailor it to your specific needs. ????

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)